← Holders
GordonMD Global Investments LP
What GordonMD Global Investments LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 2039349 · Filed Nov 16, 2026
- Positions
- 14
- Reported value
- $166.5M
- Opened
- 3
- Closed
- 5
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Dec 31, 2025$139.5M13 positions
- Mar 31, 2026$143.6M16 positions
- Jun 30, 2026$206.7M16 positions
- Sep 30, 2026$166.5M14 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
PYXSPyxis Oncology, Inc. | 15.5M | +55.0% | $36.2M | 21.8% |
KYTXKyverna Therapeutics, Inc. | 4.5M | +6.5% | $30.7M | 18.5% |
TEVATeva Pharmaceutical Industries Ltd | 379.5K | New | $15M | 9% |
CLDXCelldex Therapeutics, Inc. | 279.7K | ±0% | $9.1M | 5.4% |
TNGXTango Therapeutics, Inc. | 1.9M | New | $9M | 5.4% |
VIRVir Biotechnology, Inc. | 803.6K | −40.6% | $9M | 5.4% |
ADRXADARx Pharmaceuticals, Inc. | 450K | New | $9M | 5.4% |
ALLOAllogene Therapeutics, Inc. | 5.3M | ±0% | $8.5M | 5.1% |
BLCOBausch & Lomb Corp | 475.5K | −17.1% | $8.1M | 4.9% |
EDITEditas Medicine, Inc. | 3.1M | ±0% | $8M | 4.8% |
INCYIncyte Corp | 51.1K | +18.0% | $6.2M | 3.7% |
TSHATaysha Gene Therapies, Inc. | 248K | −65.7% | $6.2M | 3.7% |
AMGNAmgen Inc | 14.5K | −28.2% | $6.1M | 3.7% |
SRRKScholar Rock Holding Corp | 110.5K | −16.6% | $5.3M | 3.2% |